Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,488 | 625 | 99.8% |
| Education | $17.97 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,250 | 95 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,125 | 60 | $0 (2024) |
| Novo Nordisk Inc | $824.06 | 63 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $776.34 | 48 | $0 (2024) |
| Amgen Inc. | $657.84 | 41 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $541.64 | 34 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $443.26 | 29 | $0 (2024) |
| Abbott Laboratories | $360.01 | 18 | $0 (2024) |
| Merck Sharp & Dohme LLC | $284.77 | 32 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $264.85 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,153 | 65 | Lilly USA, LLC ($200.84) |
| 2023 | $1,207 | 69 | Lilly USA, LLC ($179.84) |
| 2022 | $780.64 | 50 | AstraZeneca Pharmaceuticals LP ($102.31) |
| 2021 | $381.12 | 22 | Insulet Corporation ($45.62) |
| 2020 | $169.55 | 12 | Novo Nordisk Inc ($23.81) |
| 2019 | $1,540 | 101 | Novo Nordisk Inc ($258.54) |
| 2018 | $2,145 | 148 | AstraZeneca Pharmaceuticals LP ($357.76) |
| 2017 | $2,130 | 161 | Lilly USA, LLC ($387.88) |
All Payment Transactions
628 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: DIABETES | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Cardiology | ||||||
| 12/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 11/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Rare Disease | ||||||
| 10/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Diabetes Care | ||||||
| 10/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE 365 SENSOR KIT (RETAIL) (Device) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Cardio-renal | ||||||
| 09/17/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Chiesi USA, Inc. | MYCAPSSA (Drug) | Food and Beverage | Cash or cash equivalent | $24.23 | General |
| Category: ACROMEGALY | ||||||
| 08/29/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.26 | General |
| 08/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Gastroenterology | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 07/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: DIABETES | ||||||
| 07/16/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/11/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE E3 SENSOR KIT - RETAIL (Device) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,483 | 2,159 | $412,517 | $115,480 |
| 2022 | 19 | 1,494 | 2,063 | $253,108 | $102,968 |
| 2021 | 18 | 1,456 | 2,088 | $244,538 | $100,165 |
| 2020 | 18 | 1,378 | 1,982 | $215,170 | $75,554 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 3 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 22 | 22 | $2,200 | $561.60 | 25.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 26 | 26 | $910.00 | $413.29 | 45.4% |
| 85610 | Blood test, clotting time | Office | 2021 | 14 | 90 | $900.00 | $386.10 | 42.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 33 | 33 | $1,584 | $284.96 | 18.0% |
| 81003 | Automated urinalysis test | Office | 2021 | 32 | 48 | $288.00 | $108.00 | 37.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 221 | 221 | $54,808 | $24,101 | 44.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 242 | 398 | $63,022 | $16,946 | 26.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 131 | 190 | $44,080 | $12,910 | 29.3% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 79 | 81 | $9,720 | $4,909 | 50.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 26 | 33 | $10,263 | $3,271 | 31.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 18 | 18 | $6,606 | $2,912 | 44.1% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 17 | 17 | $4,369 | $2,007 | 45.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2020 | 11 | 11 | $3,927 | $1,734 | 44.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 308 | 507 | $3,549 | $1,509 | 42.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 87 | 90 | $3,150 | $1,415 | 44.9% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 90 | 138 | $3,312 | $1,326 | 40.0% |
| 69210 | Removal of impact ear wax, one ear | Office | 2020 | 23 | 26 | $2,600 | $784.87 | 30.2% |
| 85610 | Blood test, clotting time | Office | 2020 | 18 | 115 | $1,150 | $489.39 | 42.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 26 | 26 | $910.00 | $408.22 | 44.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 30 | 33 | $1,584 | $359.45 | 22.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 11 | 28 | $980.00 | $237.60 | 24.2% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 11 | 14 | $924.00 | $154.58 | 16.7% |
| 81003 | Automated urinalysis test | Office | 2020 | 29 | 36 | $216.00 | $80.30 | 37.2% |
About Dr. Carolyn Manhart, M.D
Dr. Carolyn Manhart, M.D is a Internal Medicine healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073619458.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carolyn Manhart, M.D has received a total of $9,506 in payments from pharmaceutical and medical device companies, with $1,153 received in 2024. These payments were reported across 628 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($9,488).
As a Medicare-enrolled provider, Manhart has provided services to 5,811 Medicare beneficiaries, totaling 8,292 services with total Medicare billing of $394,166. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Omaha, NE
- Active Since 09/15/2006
- Last Updated 08/01/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1073619458
Products in Payments
- FARXIGA (Drug) $503.10
- ENTRESTO (Drug) $443.26
- JARDIANCE (Drug) $415.72
- Ozempic (Drug) $333.99
- TOUJEO (Drug) $307.37
- HUMULIN (Drug) $306.83
- EVENITY (Biological) $296.90
- TRADJENTA (Drug) $284.64
- TRULICITY (Drug) $283.88
- MOUNJARO (Drug) $275.01
- Victoza (Drug) $268.27
- Kerendia (Drug) $264.85
- SYMBICORT (Drug) $236.36
- SOLIQUA (Drug) $234.75
- Prolia (Biological) $203.20
- JANUVIA (Drug) $181.00
- ELIQUIS (Drug) $166.91
- Omnipod (Device) $160.14
- BYDUREON (Drug) $152.05
- Tymlos (Biological) $131.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Omaha
Mojtaba Akhtari, M.d, M.D
Internal Medicine — Payments: $1.6M
Dr. Matthew Lunning, D.o, D.O
Internal Medicine — Payments: $650,808
Michael Dunn, M.d, M.D
Internal Medicine — Payments: $221,491
Dr. Brian Boer, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $96,162
Dr. Trevor Van Schooneveld, M.d, M.D
Internal Medicine — Payments: $91,007
Dr. Michael Schafer, Md, MD
Internal Medicine — Payments: $60,335